Abstracts

Sleep Apnea in People With and Without HIV in Primary Care

Background: Sleep apnea negatively impacts health and quality of life. A better understanding of potential differences in sleep apnea incidence and risk factors between people with HIV (PWH) and people without HIV (PWoH) could inform prevention and management strategies. Methods: We conducted a study of adult (≥18-years-old) members of Kaiser Permanente Northern California, an integrated…

Blood Telomere Length in ART-Naive PLWH Starting DTG+3TC vs Triple Regimen With 2 Nucleosides

Background: People living with HIV (PLWH) show a marked shortening of blood telomere length (BTL) early after seroconversion. This is caused by uncontrolled viral replication with sustained immune activation, immunosenescence and inhibition of telomerase by HIV proteins. Antiretroviral therapy (ART) causes an increase in naïve and central memory cells that have longer telomeres, leading to…

Age Modifies the Association Between Sex and the Plasma Inflammatory Proteome in Treated HIV

Background: Among ART-suppressed people with HIV (PWH), women have higher levels of several plasma inflammatory markers than men, but the effect of sex on the larger plasma inflammatory proteome, and whether these differences are modified by age, remains unclear. Methods: We analyzed 363 unique plasma proteins (Olink Inflammation Explore panel) within a randomly sampled sub-cohort…

Lipidome Composition and Weight Changes at 48-week 3TC-DTG and FTC/TAF/BIC: Data of the ICONA Cohort

Background: cART start has been associated with weight gain (WG), which entails an increased dysmetabolic risk in PLWH, the biologic correlates of which are ill defined. We assessed WG and lipidome profile in cART-naïve patients starting INSTI-based dual (DT-3TC-DTG) or triple (TT-FTC/TAF/BIC) cART. Methods: We performed untargeted lipidomic on PLWH of the ICONA cohort both…

The Relationship Between Plasma Oxylipins and InSTI-Associated Weight Gain in Women Living With HIV

Background: Initiating or switching to integrase strand-transfer inhibitors (INSTIs) for HIV is associated with body weight gain, particularly in women. However, the specific mechanisms driving this effect remain unclear. Previous findings have implicated omega-6-derived poly-unsaturated fatty acids (PUFAs) as potential mediators of increased adiposity in people without HIV. This study investigated the relationship between INSTI-associated…

Dolutegravir, Body Mass Index, and Metabolic Syndrome in the IeDEA Sentinel Research Network

Background: Dolutegravir (DTG) use has been associated with increased weight compared to efavirenz in many international settings. As such, we hypothesized that DTG is also associated with greater cardiometabolic risk globally. Methods: We performed a cross-sectional study examining associations between DTG use, body mass index (BMI), and metabolic syndrome (MetS; as defined by the International…

Weight Change After Starting Doravirine Among ART-Experienced Individuals in the US

Background: Weight gain has been associated with the use of antiretrovirals (ARV), especially with integrase inhibitors (INSTI) and tenofovir alafenamide (TAF), but less so with non-nucleoside reverse transcriptase inhibitors (NNRTI). In 2018, doravirine (DOR) became the latest NNRTI to be approved. We assessed changes in weight over time after starting DOR among virologically suppressed individuals.…